[-] Show simple item record

dc.contributor.authorRaetz, Jaquelineeng
dc.contributor.authorLuft, Eric v.d. (Eric von der), 1952-eng
dc.date.issued2007-06eng
dc.description.abstractPatients with Alzheimer's disease who undergo treatment of any kind should be monitored eight weeks after initiation of therapy and at least every six months thereafter. (Strength of Recommendation: C, based on expert opinion and extrapolation from drug effectiveness studies)eng
dc.identifier.citationAmerican Family Physician, 75(11) 2007.eng
dc.identifier.urihttp://hdl.handle.net/10355/3979eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2007 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectcognitive functioneng
dc.subjectglobal functioneng
dc.subjectcholinesterase inhibitoreng
dc.subject.lcshCholinesterase inhibitorseng
dc.subject.lcshAlzheimer's disease -- Patients -- Careeng
dc.titleMonitoring Therapy for Patients with Alzheimer's Diseaseeng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record